Skip to main content
. 2016 Aug 4;6:31093. doi: 10.1038/srep31093

Figure 1. Significant downregulation of GAS5-AS1 in NSCLC tissues was correlated with tumor progression.

Figure 1

(A) qRT–PCR analysis of the relative GAS5-AS1 expression in NSCLC tumors (n = 48) and their self-paired adjacent normal lung tissues (n = 48). (Left) The expression levels of GAS5-AS1 in NSCLC tumors are shown as log2-fold change to the adjacent normal lung tissues. (Right) The data are represented as a fold-change in the tumors relative to the normal tissues. The expression of GAS5-AS1 was significantly downregulated in NSCLC tumors as compared to the normal lung tissues. (B) The expression of GAS5-AS1 was significantly lower in larger tumors. The expression of GAS5-AS1 was significantly lower in the NSCLC patients with an advanced TNM stage than those with an early TNM stage, and was also significantly lower in the NSCLC patients with lymph node metastasis than those with no lymph node metastasis.